Cancer Research Solutions

Cell-based assays are a proven and powerful tool for gaining a more complete understanding of cancer biology, providing more meaningful results in more physiologically relevant systems than classical biochemical assays - instrumental in streamlining cancer research and drug discovery.

Immuno-oncology is a leader in the worldwide drug development pipeline and is at the forefront of cancer research.

See our complete workflows which can simplify and improve the efficiency of your cell free tumor (ctDNA) research using liquid biopsies.

Single-cell analysis identifies information often overlooked by bulk approaches. We offer solutions for key steps in the single-cell sequencing workflow.

Examine the cellular response to drug exposure on live tissues to guide the right course of treatment, complementing your genomics-based approaches.

Complete, single-source target capture workflows enable cancer research by improving the efficiency of germline mutation identification.

Simplify your exosome and cfRNA research with a complete miRNAseq workflow from exoRNA delivering a high number of reads aligning to mature miRNA and low adapter dimers.

Small RNA target discovery has never been so easy with our gel-free workflow optimized to reduce bias and increase miRNA discovery even with low input samples.

Choosing the right microplate is a critical, often overlooked, part of an assay. The right microplate helps provides valuable data, whereas the wrong microplate can lead to missed or inaccurate data leading to missed project timelines and ultimately higher costs.

As many of you know, microplate readers are instruments used to detect biological, chemical, biochemical or physical events from samples in a microplate.

When the body sustains an injury, the formation of an extracellular matrix (ECM) is an important protective mechanism for tissue regeneration and healing.